Cited by 132Tryptophan and brain disordersTreatment of Major DepressionStress Responses and Cortisol

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Treatment of cytokine-induced depression

Capuron, Lucile, Hauser, Peter, Hinze-Selch, Dunja, Miller, Andrew H, Neveu, Pierre J·2002·Brain Behavior and Immunity

Open this paper in CoChat — free account

Abstract

A high proportion of cancer and hepatitis C patients who receive cytokine immunotherapy develop symptoms of depression that are indistinguishable from those found in major depressive disorders. These symptoms are alleviated by anti-depressant treatment. Moreover, preventive treatment with anti-depressants, in particular selective serotonin reuptake inhibitors (SSRIs) attenuates IFN-alpha-associated symptoms of depression, anxiety, and neurotoxicity. The intermediate mechanisms of these effects are still unclear. Studies suggest that the state of depression is associated with an increase in plasma levels of various cytokines and soluble cytokine receptors. Furthermore, anti-depressants have been shown to shift the cytokine network towards a decreased production of pro-inflammatory cytokines and an increased production of anti-inflammatory cytokines. Other studies suggest that anti-depressants can also modify immune reactivity by acting on neural structures involved in neuroimmunomodulation. It is possible that anti-depressants could help to normalize the serotoninergic neurotransmission that is likely disrupted during immunotherapy due to the potent effects of cytokines on the metabolism of the amino acid precursor tryptophan. Further work is needed to optimize strategies for preventing neuropsychiatric side effects of cytokine immunotherapy, to clarify the mechanisms involved in the alleviating effects of anti-depressants on cytokine-induced depression, as well as to assess the possible consequences of anti-depressant therapy on the efficacy of immunotherapy on the disease process.

Integrity signals

Registry

Crossref · 10.1016/s0889-1591(02)00007-7

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,089
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120
Neurobehavioral Effects of Interferon-α in Cancer Patients Phenomenology and Paroxetine Responsiveness of Symptom Dimensions
Capuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy
Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473
Self-citation
The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells
Denicoff, K. D., RUBINOW, D. R., PAPA, M. Z., SIMPSON, C., SEIPP, C. A., LOTZE, M. T., Chang, A. E., ROSENSTEIN, D., & Rosenberg, S. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-293 · Cited by 456
Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression
Maes, M. H. J., Scharpé, S., Meltzer, H. Y., Bosmans, E., Suy, E., Calabrese, J. R., & Cosyns, P. R. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90027-e · Cited by 441
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis
Haack, M., Hinze‐Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329
Mood and cognitive side effects of interferon-alpha therapy.
Valentine, A. D., Meyers, C. A., Kling, M. A., Richelson, E., & Hauser, P. (1998) · PubMed · Cited by 312
Depression‐related disturbances in mitogen‐induced lymphocyte responses and interleukin‐1β and soluble interleukin‐2 receptor production
Maes, M., Bosmans, E., Suy, E., Vandervorst, C., DeJonckheere, C., & Raus, J. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb03163.x · Cited by 268
Cytokine Production and Serum Proteins in Depression
SEIDEL, A., AROLT, V., HUNSTIGER, M., RINK, L., BEHNISCH, A., & KIRCHNER, H. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03604.x · Cited by 244

Show all 30 references

Research works printed but not linked: 2

Gumnick, 2001, The effects of paroxetine on interferon-α-induced neuropsychiatric and physical symptoms in patients witn malignant melanoma, Brain Behav. Immun., 15, 116
Schuld, 2000, Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine, Schizophr. Res., 43, 154

Sorted by citations

Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
The Semantics of Microglia Activation: Neuroinflammation, Homeostasis, and Stress
Woodburn, S. C., Bollinger, J. L., & Wohleb, E. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02309-6 · Cited by 783
The kynurenine pathway: a finger in every pie
Savitz, J. B. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0414-4 · Cited by 805
Major depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 471
The menace of obesity to depression and anxiety prevalence
Fulton, S., Décarie-Spain, L., Fioramonti, X., Guiard, B., & Nakajima, S. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.10.005 · Cited by 441
“observations that inflammatory interventions can lead to symptoms of these disorders, such as in the case of patients receiving interferon (IFN) alpha treatment [64].”
Background
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 445
Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise
Felger, J. C., & Miller, A. H. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.003 · Cited by 412
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 341
Brain-Gut-Microbiota Axis and Mental Health
Dinan, T. G., & Cryan, J. F. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000519 · Cited by 325
Serotonin and Human Cognitive Performance
Schmitt, J. A. J., Wingen, M., Ramaekers, J. G., Evers, E. A. T., & Riedel, W. J. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698909 · Cited by 260
Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology
Goldsmith, D. R., Bekhbat, M., Mehta, N. D., & Felger, J. C. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.003 · Cited by 226
Neuropathology of mood disorders: Do we see the stigmata of inflammation?
Mechawar, N., & Savitz, J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.212 · Cited by 165
TNF-α-mediated anxiety in a mouse model of multiple sclerosis
Haji, N., Mandolesi, G., Gentile, A., Sacchetti, L., Fresegna, D., Rossi, S., Musella, A., Sepman, H., Motta, C., Studer, V., et al. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.07.010 · Cited by 164
Glucocorticoid Dysregulations and Their Clinical Correlates: From Receptors to Therapeutics
Marques, A. H., Silverman, M. N., & Sternberg, E. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04987.x · Cited by 158
The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150
Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder
Tucker, P., Ruwe, W. D., Masters, B., Parker, D. E., Hossain, A., Trautman, R. P., & Wyatt, D. B. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.009 · Cited by 148
Pro-inflammatory biomakers in depression: Treatment with venlafaxine
Piletz, J. E., Halaris, A. E., Iqbal, O., Hoppensteadt, D., Fareed, J., Zhu, H., Sinacore, J. M., & DeVane, C. L. (2008) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802573246 · Cited by 139
Inflammation is increased with anxiety- and depression-like signs in a rat model of spinal cord injury
Maldonado‐Bouchard, S., Peters, K., Woller, S. A., Madahian, B., Faghihi, U., Patel, S. P., Bake, S., & Hook, M. A. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.08.009 · Cited by 133
Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms
Engler, H., Brendt, P., Wischermann, J., Wegner, A., Rohling, R., Schoemberg, T., Meyer, U., Gold, R., Peters, J., Benson, S., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.264 · Cited by 127
Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism?
Park, C., Brietzke, E. M., Rosenblat, J. D., Musial, N., Zuckerman, H., Ragguett, R., Pan, Z., Rong, C., Fus, D., & McIntyre, R. S. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.07.006 · Cited by 131
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood
Grudet, C., Malm, J., Westrin, Å., & Brundin, L. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.08.016 · Cited by 112
Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task
Nunes, E. J., Randall, P. A., Estrada, A., Epling, B. P., Hart, E. E., Lee, C. A., Baqi, Y., Müller, C. E., Correa, M., & Salamone, J. D. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3285-4 · Cited by 108
Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?
McNamara, R. K., & Lotrich, F. E. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.98 · Cited by 111
Innate immunity in the postmortem brain of depressed and suicide subjects: Role of Toll-like receptors
Pandey, G. N., Rizavi, H. S., Bhaumik, R., & Ren, X. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.024 · Cited by 110
Depression and Chronic Diseases: It Is Time for a Synergistic Mental Health and Primary Care Approach
Voinov, B., Richie, W. D., & Bailey, R. K. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.12r01468 · Cited by 98
Prophylactic SSRI during interferon alpha re‐therapy in patients with chronic hepatitis C and a history of interferon‐induced depression
Kraus, M. R., Schäfer, A., Al‐Taie, O., & Scheurlen, M. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00554.x · Cited by 96
Feeding melancholic microbes: MyNewGut recommendations on diet and mood
Dinan, T. G., Stanton, C., Long-Smith, C., Kennedy, P., Cryan, J. F., Cowan, C. S. M., Cenit, M. C., van der Kamp, J.-W., & Sanz, Y. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.11.010 · Cited by 95
Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders
Savitz, J. B. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_12 · Cited by 98
Serum kynurenic acid is reduced in affective psychosis
Wurfel, B. E., Drevets, W. C., Bliss, S. A., McMillin, J. R., Suzuki, H., Ford, B. N., Morris, H. M., Teague, T. K., Dantzer, R., & Savitz, J. B. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.88 · Cited by 91
Role of Inflammation in Depression and Treatment Implications
Felger, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_166 · Cited by 95
The emerging tale of microglia in psychiatric disorders
Rahimian, R., Wakid, M., O’Leary, L. A., & Mechawar, N. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.023 · Cited by 95
Role of IL-1 in Poststroke Depressive-like Behavior in Mice
Craft, T. K. S., & DeVries, A. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.011 · Cited by 87
Microglia activation is associated with IFN-α induced depressive-like behavior
Wachholz, S., Eßlinger, M., Plümper, J., Manitz, M. P., Juckel, G., & Friebe, A. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.09.016 · Cited by 84
Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain
Laumet, G. O., Zhou, W., Dantzer, R., Edralin, J. D., Huo, X., Budac, D. P., O’Connor, J. C., Lee, A. W., Heijnen, C. J., & Kavelaars, A. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.07.008 · Cited by 87
The Role of Cytokines in the Regulation of Neurotransmission
Camacho‐Arroyo, I., López-Griego, L., & Morales‐Montor, J. (2008) · NeuroImmunoModulation · doi:10.1159/000179661 · Cited by 78
The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
Hestad, K. A., Engedal, K., Whist, J. E., & Farup, P. G. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.01561 · Cited by 76
Major depression during interferon-α treatment: vulnerability and prevention
Lotrich, F. E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.4/felotrich · Cited by 71
Fibromyalgia: Present to future
Bennett, R. M. (2005) · Current Rheumatology Reports · doi:10.1007/s11926-005-0022-y · Cited by 71
Perioperative neurocognitive dysfunction: thinking from the gut?
Xu, X., Hu, Y., Yan, E., Zhan, G., Liu, C., & Yang, C. (2020) · Aging · doi:10.18632/aging.103738 · Cited by 71
Depression subtypes in pediatric inflammatory bowel disease
Szigethy, E. M., Youk, A. O., Benhayon, D., Fairclough, D. L., Newara, M. C., Kirshner, M. A., Bujoreanu, S. I., Mrakotsky, C., Bousvaros, A., Srinath, A. I., et al. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000262 · Cited by 65
Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience
Flux, M. C., & Lowry, C. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104578 · Cited by 70
Psychosocial influences on immunity, including effects on immune maturation and senescence
Coe, C. L., & Laudenslager, M. L. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.06.015 · Cited by 62
Depression, cytokines, and glial function
Miller, D. B., & O'Callaghan, J. P. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.011 · Cited by 62
The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-α induced alterations to monoamine turnover in prefrontal cortex and hippocampus
Garza, R. D. L., & Asnis, G. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02757-4 · Cited by 64
Depressive-like behavior induced by tumor necrosis factor-α is abolished by agmatine administration
Neis, V. B., Manosso, L. M., Moretti, M., Freitas, A. E., Daufenbach, J., & Rodrigues, A. L. S. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.038 · Cited by 59
Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?
Kenis, G., Prickaerts, J., van Os, J., Koek, G. H., Robaeys, G., Steinbusch, H. W. M., & Wichers, M. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000830 · Cited by 58
Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents
Mamalakis, G., Kiriakakis, M., Tsibinos, G., Hatzis, C., FLOURI, S., Mantzoros, C. S., & Kafatos, A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.008 · Cited by 56
Cognitive changes after acute tryptophan depletion: what can they tell us?
Riedel, W. J. (2004) · Psychological Medicine · doi:10.1017/s0033291703008924 · Cited by 55
Toxicity as a result of immunostimulation by biologics
Gribble, E. J., Sivakumar, P. V., Ponce, R. A., & Hughes, S. D. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.2.209 · Cited by 51
Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression
Bassi, M. S., Gilio, L., Maffei, P., Dolcetti, E., Bruno, A., Buttari, F., Centonze, D., & Iezzi, E. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00424 · Cited by 51
Sick and grumpy: Changes in social behaviour after a controlled immune stimulation in group-housed gilts
Munsterhjelm, C., Nordgreen, J., Aae, F., Heinonen, M., Valros, A., & Janczak, A. M. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.09.018 · Cited by 48
New lung cancer treatments (immunotherapy and targeted therapies) and their associations with depression and other psychological side effects as compared to chemotherapy
McFarland, D. C. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.04.001 · Cited by 50
Drug disease interactions: role of inflammatory mediators in depression and variability in antidepressant drug response.
Kulmatycki, K. M., & Jamali, F. (2006) · PubMed · Cited by 43
Potential roles for opioid receptors in motivation and major depressive disorder
Callaghan, C. K., Rouine, J., & O’Mara, S. M. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.07.009 · Cited by 45
Stress circuitry: mechanisms behind nervous and immune system communication that influence behavior
Tong, R. L., Kahn, U. N., Grafe, L. A., Hitti, F. L., Fried, N. T., & Corbett, B. F. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1240783 · Cited by 43
Psychiatric Problems in Patients Infected with Hepatitis C Before and During Antiviral Treatment with Interferon-Alpha: A Review
Quelhas, R., & Lopes, A. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000358313.06858.ea · Cited by 40
Hepatitis C Treatment for People With Severe Mental Illness
Mistler, L. A., Brunette, M. F., Marsh, B. J., Vidaver, R. M., Luckoor, R., & Rosenberg, S. D. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.2.93 · Cited by 39
Fibromyalgia: Present to future
Bennett, R. M. (2004) · Current Pain and Headache Reports · doi:10.1007/s11916-996-0011-5 · Cited by 39
Association between plasma inflammatory markers and irrational beliefs; the ATTICA epidemiological study
Papageorgiou, C., Panagiotakos, D. B., Pitsavos, C. S., Tsetsekou, E., Kontoangelos, K. A., Stefanadis, C., & Soldatos, C. R. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.05.018 · Cited by 38
Adverse Consequences of Immunostimulation
Ponce, R. A. (2008) · Journal of Immunotoxicology · doi:10.1080/15476910801897920 · Cited by 35
Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders
Kalinichenko, L. S., Kornhuber, J., & Müller, C. P. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100783 · Cited by 35
The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release
Garza, R. D. L. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00211-0 · Cited by 33
Amitriptyline, clomipramine, and maprotiline attenuate the inflammatory response by inhibiting neutrophil migration and mast cell degranulation
Gurgel, J. A., Lima‐Júnior, R. C. P., Rabelo, C. O., Pessoa, B. B. G. D. P., Brito, G. A. D. C., & Ribeiro, R. A. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2012-0977 · Cited by 32
C‐reactive protein and its association with depression in patients receiving treatment for metastatic lung cancer
McFarland, D. C., Shaffer, K. M., BREITBART, W. S., Rosenfeld, B. D., & Miller, A. H. (2018) · Cancer · doi:10.1002/cncr.31859 · Cited by 32
Tumor Mutation Burden and Depression in Lung Cancer: Association With Inflammation
McFarland, D. C., Jutagir, D. R., Miller, A. H., BREITBART, W. S., Nelson, C. J., & Rosenfeld, B. D. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.7374 · Cited by 30
A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics?
Eltokhi, A., & Sommer, I. E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.852506 · Cited by 32
Time-dependent in-vivo effects of interleukin-2 on neurotransmitters in various cortices: Relationships with depressive-related and anxiety-like behaviour
Karrenbauer, B. D., Müller, C. P., Ho, Y., Spanagel, R., Huston, J. P., Schwarting, R. K. W., & Pawlak, C. R. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.05.011 · Cited by 29
Genetic susceptibility, inflammation and specific types of depressive symptoms: evidence from the English Longitudinal Study of Ageing
Frank, P., Ajnakina, O., Steptoe, A., & Cadar, D. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0815-9 · Cited by 29
Linking depression and neuroinflammation: Crosstalk between glial cells
Yang, X., Wang, H., Wang, Z.-Z., & Chen, N. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177408 · Cited by 26
Astrocytic TNFα regulates the behavioral response to antidepressants
Duseja, R., Heir, R., Lewitus, G. M., Altimimi, H. F., & Stellwagen, D. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.09.012 · Cited by 25
Psychobiotics: Evolution of Novel Antidepressants
Dinan, T. G., Butler, M., & Cryan, J. F. (2021) · Modern trends in psychiatry · doi:10.1159/000510424 · Cited by 26
Mental health is the health of the whole body: How psychoneuroimmunology & health psychology can inform & improve treatment
Alessi, M. G., & Bennett, J. M. (2020) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13386 · Cited by 28
Uncoupling protein 2 knockout exacerbates depression-like behaviors in mice via enhancing inflammatory response
Sun, X., Liu, Y., Dai, T., Ding, J. H., & Hu, G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.047 · Cited by 24
The Association between Low Vitamin D Levels and Suicide Attempts in Adolescents
Gökalp, G. (2020) · Annals of Clinical Psychiatry · doi:10.1177/104012372003200208 · Cited by 20
Inflammation and its relevance to psychiatry
Cavanagh, J., & Mathias, C. (2008) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.106.003319 · Cited by 20
Changes in Depressive Symptoms and Impact on Treatment Course Among Hepatitis C Patients Undergoing Interferon-α and Ribavirin Therapy: A Prospective Evaluation
Chapman, J., Oser, M. L., Hockemeyer, J. R., Weitlauf, J. C., Jones, S., & Cheung, R. C. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.252 · Cited by 19
Assessment of health‐related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C
Matsushita, H., Ikeda, F., Iwasaki, Y., Seki, H., Nanba, S., Takeuchi, Y., Moritou, Y., Yasunaka, T., Onishi, H., Miyake, Y., et al. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12337 · Cited by 18
Factors associated with the initiation of alpha‐interferon treatment in Medicaid patients diagnosed with hepatitis C
Markowitz, J. S., Gutterman, E. M., Hodes, D. S., & Klaskala, W. I. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00607.x · Cited by 17
Negative correlations of psychological distress with quality of life and immunotherapy efficacy in patients with advanced NSCLC.
Bi, Z., Li, W., Zhao, J., Pang, L., Jing, Y., Zhang, X., Yao, S., Yin, X., Zuo, H., & Cheng, H. (2022) · PubMed Central · Cited by 17
The Contribution of TNFα to Synaptic Plasticity and Nervous System Function
Stellwagen, D. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6612-4_57 · Cited by 15
Do different depression phenotypes have different risks for recurrent coronary heart disease?
Shaffer, J. A., Whang, W., Shimbo, D., Burg, M. M., Schwartz, J. E., & Davidson, K. W. (2011) · Health Psychology Review · doi:10.1080/17437199.2010.527610 · Cited by 14
Meta-analysis of soluble tumour necrosis factor receptors in severe mental illnesses
Goh, X. X., Tang, P. Y., & Tee, S. F. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.07.014 · Cited by 14
Knockout of NPFFR2 Prevents LPS-Induced Depressive-Like Responses in Mice
Yu, Z., Lin, Y., & Chen, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147611 · Cited by 13
Hepatitis C and Psychiatry
Rifai, M. A., & Rosenstein, D. L. (2005) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.3.2.194 · Cited by 13
The complex relationship between gut microbiota dysregulation and mood disorders: A narrative review
Minuti, A., Brufani, F., Menculini, G., Moretti, P., & Tortorella, A. A. V. (2022) · Current Research in Neurobiology · doi:10.1016/j.crneur.2022.100044 · Cited by 13
Psychiatric Clearance for Patients Started on Interferon-Alpha-Based Therapies
Lotrich, F. E. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12121572 · Cited by 12
The janus face of serotonin: Regenerative promoter and chronic liver disease aggravator
Mao, B., Liu, S., Zhu, S., Wu, F., Yuan, W., Yan, Y., & Wang, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30703 · Cited by 10
Effects of selective serotonin reuptake inhibitors on platelet functions: a literature review
Mokhtarian, A., Siguret, V., & Jourdi, G. (2024) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000847 · Cited by 10
Building a replicable and clinically-impactful immunopsychiatry: Methods, phenotyping, and theory integration
Moriarity, D. P. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100288 · Cited by 11
Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders
Ballaz, S., & Bourin, M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_20 · Cited by 9
Psychiatric Assessment of Patients With Hepatitis C Virus Before Initiating Interferon Treatment
Goldsmith, R. J., Mindrum, G. M., & Myaing, M. (2003) · Psychiatric Annals · doi:10.3928/0048-5713-20030601-06 · Cited by 9
Inflammation as a mediator of stress-related psychiatric disorders
Flux, M. C., & Lowry, C. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00052-6 · Cited by 9
Targeting brain connectivity in Alzheimer’s disease with repurposed drugs
Pini, L., Imbimbo, B. P., Griffa, A., Allali, G., & Pomara, N. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.103001 · Cited by 7
The next generation of collaborative care: The design of a novel web-based stepped collaborative care intervention delivered via telemedicine for people diagnosed with cancer
Steel, J. L., Reyes, V. E., Zandberg, D. P., Nilsen, M. L., Terhorst, L. A., Richards, G., Pappu, B., Kiefer, G. J., Johnson, J. T., Antoni, M. H., et al. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106295 · Cited by 6
Advances in Stem Cells Biology: New Approaches to Understand Depression
Borsini, A., & Zunszain, P. A. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-41603-8_10 · Cited by 5
Inflammatory Markers in Acute Myocardial Infarction Patients: Preliminary Evidence of a Prospective Association With Depressive Symptoms
Hekler, E. B., Rubenstein, J., Coups, E. J., Gilligan, S., Kusnecov, A. W., Contrada, R. J., Steiner, M. J., Tannenbaum, A. K., Leventhal, E. A., & Krause, T. J. (2007) · Journal of Applied Biobehavioral Research · doi:10.1111/j.1751-9861.2007.00014.x · Cited by 5
Identification of Gene Co-Expression Modules and Core Genes Related to Immune Disorders in Major Depression Disorder
Zhang, L., Zhang, H., Xie, J., & Wang, X. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s336686 · Cited by 4
Association of Baseline Sleep Quality With Trajectories of Depressive Symptoms in Patients Undergoing Interferon Treatment
Marron, M. M., Anderson, S., Garrity, J., Reynolds, C. F., & Lotrich, F. E. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000231 · Cited by 4

Authors: Capuron, L., Hauser, P., Hinze-Selch, D., Miller, A. H., & Neveu, P. J.
Affiliations: Emory University (US)
Université de Bordeaux (FR)
Corresponding author: Neveu, Pierre J
ORCID: Capuron, Lucile
Venue: Brain Behavior and Immunity
Publisher: Elsevier BV
Published: 2002-10
Volume: 16
Issue: 5
Pages: 575-580
ISSN: 0889-1591 (ISSN-L)
DOI: 10.1016/s0889-1591(02)00007-7
OpenAlex: W2002423129
Cited by: 132
References: 30
Citations by year: 2026: 2 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 6 · 2019: 6 · 2018: 9 · 2017: 7 · 2016: 7 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 4
FWCI: 0.66
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Brain Behavior and Immunity (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords: cytokine therapy, antidepressants, selective serotonin reuptake inhibitors, interferon-alpha, cancer patients, hepatitis C, neurotoxicity, anxiety, neuroimmunomodulation, serotonergic neurotransmission, tryptophan metabolism, inflammatory cytokines, anti-inflammatory cytokines, soluble cytokine receptors, neuropsychiatric adverse effects
MeSH terms: Antidepressive Agents, Depressive Disorder, Humans, Immunotherapy, Serotonin, Sleep, Tryptophan, Cytokines, Receptors, Cytokine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Treatment of cytokine-induced depression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks